What is 20-yr risk of metastatic recurrence in Stage 1A Estrogen +, HER2- breast cancer patients after five years of tamoxifen or AI? 10-17%. (Pan, NEJM 2017) Endocrine therapy lowers risk of recurrence by 47%, so you can do the math for those who do not take it. #bcsm

This morning, I had the honor of presenting my first Rapid Oral at #ASCO25 🎤 — a truly unforgettable experience ✨. Our study highlights the rising burden of #alcohol-associated cancers 🍷🎗️ across sites, age groups, and sexes gilberto lopes Dr. Estela Rodriguez . Grateful to all my mentors

Our fellows and residents continue to shine at #ASCO25! 🌟 Proud to see their hard work translating into impactful academic contributions. Here are more poster presentations from our trainees 🙌🧬 Dan Morgenstern, MD, MSc Chinmay Jani Sylvester Comprehensive Cancer Center Priscila Barreto Coelho, MD Gina Z. D'Amato, MD. Dr. Estela Rodriguez

📍Check out our ASCO poster (Board A136) on the Adequacy of Thyroid Function Monitoring after ICI therapy. ⭐️ Post-ICI thyroid dysfunction is common but often underdiagnosed due to limited surveillance. 🔎 Findings underscore the need for extended TFT monitoring post-treatment.

Shocking data 🤯 Effect size is huge, way larger than expected Urgent to seek reproduction/validation of the finding in further studies, given the potential implications on clinical practice and clinical trials (across oncology fields)

#SOFT and #TEXT looking at AI vs. tam and OFS vs. not, 15 yr f/u 📌Adding OFS gives you 3.7% ⬆️ DFS 📌OFS + AI gets you 6.5% ⬆️ DFS 📍OFS + AI improves gives you ⬆️ 4.3% OS 🌟 Ultra young <35, it's even more important #ASCO25 #bcsm

🔥 Congrats to my friend and future Hem-Onc Fellows Network Dan Morgenstern, MD, MSc at Miami Hem/Onc Program Director Sylvester Comprehensive Cancer Center for leading this cutting-edge poster at #ASCO25 on the multiomic landscape of LRRC15 in #TNBC 🧬💥 Major findings: 🔹 LRRC15-High tumors = ↑ PD-L1, ↑ CAFs, ↑ T-cell inflamed & IFNγ

Super 🌟 fellow and upcoming chief 👏🏽

What a pleasure (and lots of learning!) bringing today’s updates via OncLive.com! #ASCO25 is truly the place to #betogether, #beinspired, and #belong. Grateful to be part of this vibrant oncology community! Sylvester Comprehensive Cancer Center Miami Hem/Onc Program Director

⭐️Congratulations to Dr. Sara Tolaney Sara Tolaney Dana-Farber and the #DestinyBreast09 investigators for a TRANSFORMATIVE study for 1st line metastatic HER2+ breast cancer. #ASCO25 Really enjoyed talking to Dr. Giuseppe Curigliano on the HER2 story. G Curigliano MD PhD Gevorg Tamamyan

Yesterday’s update of #SOFT #TEXT made me think of an important point. Be very careful (or just don’t) tell a premenopausal pt “your recurrence risk is X”- whatever their Oncotype says it is. That is in the next 9 years!!! A premenopausal patient wants to live 60 years.! Oncotype

Oncologists Arriving at ASCO Returning from ASCO #ASCO25

#ASCO2025 was filled with groundbreaking science. Feeling inspired and grateful to be part of this community. These are just a few of the top breast cancer studies presented, and some of the remaining questions.

Grateful to have completed the JCO Editorial Fellowship @JCOOP_Journal alongside Yenong Cao , mentored by Dr. Raghavan, Dr. Peppercorn, and Kelly Brooks. A year of growth and a project now coming to fruition. Editorial work shapes the future of oncology—thank you for the

Thrilled to officially join the 2025–2026 ASCO Trainee & Early Career Advisory Group (ASCO TECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the

Getting inspiration from Castaways today! 26th annual 170 mile paddle, pedal or run: Miami to Key West. All to support much needed #CancerResearch Sylvester Comprehensive Cancer Center Juan P. Alderuccio

Lucky me that I get to work in the Sylvester Comprehensive Cancer Center brand new Kenneth Griffin Research Bldg. Experimental Therapeutics Clinic with amazing research leaders in the field with Craig Moskowitz, MD Jose Lutzky, MD, FACP Mikkael A. Sekeres MD, MS #researchmatters

Mark your calendar for July 30th at 6 PM for a CE Dinner Meeting on #BreastCancer in #Miami! 🌟Free CME/CNE/CPE Credit | No Cost to Participate 🌟 Priscila Barreto Coelho, MD 📍 RSVP now: ow.ly/nzgo50W5xSz #miamihealthcare #MedTwitter #CME #CNE #ContinuingEducation #MedLearningGroup

A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environment. #bcsm knowablemagazine.org/content/articl…